R-Tech Ueno Overview

  • Year Founded
  • 1989

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 80

Employees

  • Latest Deal Type
  • PIPE

  • Latest Deal Amount
  • $10M

R-Tech Ueno General Information

Description

Developer of pharmaceuticals intended to develop solutions for unmet medical needs. The company is a Japanese pharmaceutical company that manufactures AMITIZA for Sucampo and Sucampo's commercialization partners, enabling its clients with research and development, manufacturing and marketing of drugs, development support, and contract manufacturing services.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • NBF Hibiya Builing 10th Floor
  • 1-1-7 Uchisaiwaicho Chiyoda-ku
  • Tokyo, 100-0011
  • Japan
Primary Industry
Drug Delivery
Other Industries
Drug Discovery
Corporate Office
  • NBF Hibiya Builing 10th Floor
  • 1-1-7 Uchisaiwaicho Chiyoda-ku
  • Tokyo, 100-0011
  • Japan

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

R-Tech Ueno Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. PIPE 22-Oct-2015 $10M Completed Profitable
3. Merger/Acquisition 13-Oct-2015 Completed Profitable
2. IPO 01-Mar-2008 Completed Profitable
1. Early Stage VC Completed Profitable
To view R-Tech Ueno’s complete valuation and funding history, request access »

R-Tech Ueno Patents

R-Tech Ueno Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20170020890-A1 Pharmaceutical composition comprising fatty acid derivative Inactive 19-Jun-2015
WO-2016203317-A1 Pharmaceutical compositions comprising fatty acid derivative Inactive 19-Jun-2015
JP-2018076236-A Pharmaceutical composition for treating cancer Pending 05-Jun-2015
WO-2016194390-A1 Pharmaceutical composition for use in the treatment of cancer Inactive 05-Jun-2015
JP-2018080114-A Anti-human vap-1 monoclonal antibody Pending 29-May-2015 C07K16/40
To view R-Tech Ueno’s complete patent history, request access »

R-Tech Ueno Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

R-Tech Ueno Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Nissay Capital Venture Capital Minority
To view R-Tech Ueno’s complete investors history, request access »

R-Tech Ueno FAQs

  • When was R-Tech Ueno founded?

    R-Tech Ueno was founded in 1989.

  • Where is R-Tech Ueno headquartered?

    R-Tech Ueno is headquartered in Tokyo, Japan.

  • What is the size of R-Tech Ueno?

    R-Tech Ueno has 80 total employees.

  • What industry is R-Tech Ueno in?

    R-Tech Ueno’s primary industry is Drug Delivery.

  • Is R-Tech Ueno a private or public company?

    R-Tech Ueno is a Private company.

  • What is the current valuation of R-Tech Ueno?

    The current valuation of R-Tech Ueno is .

  • What is R-Tech Ueno’s current revenue?

    The current revenue for R-Tech Ueno is .

  • How much funding has R-Tech Ueno raised over time?

    R-Tech Ueno has raised $10M.

  • Who are R-Tech Ueno’s investors?

    Nissay Capital has invested in R-Tech Ueno.

  • When was R-Tech Ueno acquired?

    R-Tech Ueno was acquired on 22-Oct-2015.

  • Who acquired R-Tech Ueno?

    R-Tech Ueno was acquired by Sucampo Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process